Dendritic Cells in Transplantation and Immune-Based Therapies

Langerhans, 1868, Ueber die nerven der menschlichen haut, Arch Pathol Anat Physiol Klin Med Berlin, 44, 325 Steinman, 1973, Identification of a novel cell type in peripheral lymphoid organs of mice, J Exp Med, 137, 1142, 10.1084/jem.137.5.1142 Grouard, 1997, The enigmatic plasmacytoid T cells develop into dendritic cells with IL-3 and CD40-ligand, J Exp Med, 185, 1101, 10.1084/jem.185.6.1101 Siegal, 1999, The nature of the principal type 1 interferon-producing cells in human blood, Science, 284, 1835, 10.1126/science.284.5421.1835 Cella, 1999, Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon, Nat Med, 5, 919, 10.1038/11360 Fonteneau, 2003, Activation of influenza virus–specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity, Blood, 101, 3520, 10.1182/blood-2002-10-3063 Zhou, 1995, Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily, J Immunol, 154, 3821 Asselin-Paturel, 2001, Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology, Nat Immunol, 2, 1144, 10.1038/ni736 Nakano, 2001, CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells, J Exp Med, 194, 1171, 10.1084/jem.194.8.1171 Jonuleit, 2003, The regulatory T cell family: distinct subsets and their interrelations, J Immunol, 171, 6323, 10.4049/jimmunol.171.12.6323 Moseman, 2004, Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells, J Immunol, 173, 4433, 10.4049/jimmunol.173.7.4433 Gilliet, 2002, Generation of human CD8 T regulatory cells by CD40 ligand–activated plasmacytoid dendritic cells, J Exp Med, 195, 695, 10.1084/jem.20011603 Banerjee, 2006, Expansion of FOXP3 high-regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients, Blood, 108, 2655, 10.1182/blood-2006-03-011353 Hawiger, 2001, Dendritic cells induce peripheral T cell unresponsiveness under steady-state conditions in vivo, J Exp Med, 194, 769, 10.1084/jem.194.6.769 Bonifaz, 2002, Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T-cell tolerance, J Exp Med, 196, 1627, 10.1084/jem.20021598 Lutz, 2002, Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?, Trends Immunol, 23, 445, 10.1016/S1471-4906(02)02281-0 Jonuleit, 1997, Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions, Eur J Immunol, 27, 3135, 10.1002/eji.1830271209 Albert, 1998, Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs, Nature, 392, 86, 10.1038/32183 Guermonprez, 2003, ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells, Nature, 425, 397, 10.1038/nature01911 Ackerman, 2005, Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells, Nat Immunol, 6, 107, 10.1038/ni1147 Ratzinger, 2004, J Immunol, 173, 2780, 10.4049/jimmunol.173.4.2780 Goldszmid, 2003, Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T-cell immunity against B16 melanoma, J Immunol, 171, 5940, 10.4049/jimmunol.171.11.5940 Kadowaki, 2001, Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens, J Exp Med, 194, 863, 10.1084/jem.194.6.863 Jarrossay, 2001, Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells, Eur J Immunol, 31, 3388, 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q Valladeau, 2000, Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules, Immunity, 12, 71, 10.1016/S1074-7613(00)80160-0 Ebner, 2004, Expression of C-type lectin receptors by subsets of dendritic cells in human skin, Int Immunol, 16, 877, 10.1093/intimm/dxh088 Bonifaz, 2004, In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination, J Exp Med, 199, 815, 10.1084/jem.20032220 Gantner, 2003, Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2, J Exp Med, 197, 1107, 10.1084/jem.20021787 Ravetch, 2001, IgG Fc receptors, Annu Rev Immunol, 19, 275, 10.1146/annurev.immunol.19.1.275 Boruchov, 2005, Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions, J Clin Invest, 115, 2914, 10.1172/JCI24772 Kalergis, 2002, Inducing tumor immunity through the selective engagement of activating Fc-gamma receptors on dendritic cells, J Exp Med, 195, 1653, 10.1084/jem.20020338 Dhodapkar, 2002, Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells, J Exp Med, 195, 125, 10.1084/jem.20011097 Banchereau, 2001, Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine, Cancer Res, 61, 6451 Ebner, 2001, Production of IL-12 by human monocyte–derived dendritic cells is optimal when the stimulus Is given at the onset of maturation, and is further enhanced by IL-4, J Immunol, 166, 633, 10.4049/jimmunol.166.1.633 Trinchieri, 2003, Interleukin-12 and the regulation of innate resistance and adaptive immunity, Nat Rev Immunol, 3, 133, 10.1038/nri1001 Mailliard, 2003, Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function, J Immunol, 171, 2366, 10.4049/jimmunol.171.5.2366 Martin-Fontecha, 2004, Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming, Nat Immunol, 5, 1260, 10.1038/ni1138 Munz, 2005, Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells, Blood, 105, 266, 10.1182/blood-2004-06-2492 Taniguchi, 2003, The NKT cell system: bridging innate and acquired immunity, Nat Immunol, 4, 1164, 10.1038/ni1203-1164 Wu, 2003, Cross-presentation of disialoganglioside GD3 to natural killer T cells, J Exp Med, 198, 173, 10.1084/jem.20030446 Fujii, 2002, Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs, Nat Immunol, 3, 867, 10.1038/ni827 Fujii, 2003, Activation of natural killer T cells by {alpha}-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T-cell immunity to a coadministered protein, J Exp Med, 198, 267, 10.1084/jem.20030324 Dhodapkar, 2003, A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma, J Exp Med, 197, 1667, 10.1084/jem.20021650 Brigl, 2003, Mechanism of CD1d-restricted natural killer T cell activation during microbial infection, Nat Immunol, 4, 1230, 10.1038/ni1002 Korngold, 1978, Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice, J Exp Med, 148, 1687, 10.1084/jem.148.6.1687 Korngold, 1980, Selection of cytotoxic T-cell precursors specific for minor histocompatibility determinants. 1, J Exp Med, 151, 314, 10.1084/jem.151.2.314 Sherman, 1993, The molecular basis of allorecognition, Ann Rev Immunol, 11, 385, 10.1146/annurev.iy.11.040193.002125 Bleakley, 2004, Molecules and mechanisms of the graft-versus-leukaemia effect, Nat Rev Cancer, 4, 371, 10.1038/nrc1365 Shlomchik, 1999, Prevention of graft versus host disease by inactivation of host antigen-presenting cells, Science, 285, 412, 10.1126/science.285.5426.412 Duffner, 2004, Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease, J Immunol, 172, 7393, 10.4049/jimmunol.172.12.7393 Matte, 2004, Donor APCs are required for maximal GVHD but not for GVL, Nat Med, 10, 987, 10.1038/nm1089 Merad, 2002, Langerhans cells renew in the skin throughout life under steady-state conditions, Nat Immunol, 3, 1135, 10.1038/ni852 Merad, 2004, Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease, Nat Med, 10, 510, 10.1038/nm1038 Collin, 2006, The fate of human Langerhans cells in hematopoietic stem cell transplantation, J Exp Med, 203, 27, 10.1084/jem.20051787 Hill, 2000, The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation, Blood, 95, 2754, 10.1182/blood.V95.9.2754.009k25_2754_2759 Auffermann-Gretzinger, 2002, Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients, Blood, 99, 1442, 10.1182/blood.V99.4.1442 Reddy, 2004, Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease, Blood, 103, 4330, 10.1182/blood-2003-09-3325 Auffermann-Gretzinger, 2006, Fast appearance of donor dendritic cells in human skin: dynamics of skin and blood dendritic cells after allogeneic hematopoietic cell transplantation, Transplantation, 81, 866, 10.1097/01.tp.0000203318.16224.57 Klangsinsirikul, 2002, Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution, Blood, 99, 2586, 10.1182/blood.V99.7.2586 Ratzinger, 2003, Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft–host interactions in transplantation, Blood, 101, 1422, 10.1182/blood-2002-04-1093 Collin, 2005, In vitro depletion of tissue-derived dendritic cells by CMRF-44 antibody and alemtuzumab: implications for the control of graft-versus-host disease, Transplantation, 79, 722, 10.1097/01.TP.0000149321.86104.C4 Lee, 2005, Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells, Blood, 105, 3951, 10.1182/blood-2004-10-3927 Hackstein, 2003, Rapamycin inhibits IL-4–induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo, Blood, 101, 4457, 10.1182/blood-2002-11-3370 Papadopoulos, 1998, T-cell–depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease, Blood, 91, 1083, 10.1182/blood.V91.3.1083 Mackinnon, 1995, Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease, Blood, 86, 1261, 10.1182/blood.V86.4.1261.bloodjournal8641261 Zhang, 2004, Dendritic cell–activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity, Blood, 103, 3970, 10.1182/blood-2003-09-3135 Durakovic, 2006, Host-derived Langerhans cells persist after MHC-matched allografting independent of donor T cells and critically influence the alloresponses mediated by donor lymphocyte infusions, J Immunol, 177, 4414, 10.4049/jimmunol.177.7.4414 Hsu, 1996, Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells, Nat Med, 2, 52, 10.1038/nm0196-52 Timmerman, 2002, Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients, Blood, 99, 1517, 10.1182/blood.V99.5.1517 Dzionek, 2000, BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood, J Immunol, 165, 6037, 10.4049/jimmunol.165.11.6037 Lopez, 2003, Single step enrichment of blood dendritic cells by positive immunoselection, J Immunol Methods, 274, 47, 10.1016/S0022-1759(02)00429-5 Berard, 2000, Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells, J Exp Med, 192, 1535, 10.1084/jem.192.11.1535 Palucka, 2006, Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1–specific CD8+ T-cell immunity, J Immunother, 29, 545, 10.1097/01.cji.0000211309.90621.8b Yuan, 2006, Langerhans-type dendritic cells genetically modified to express full-length antigen optimally stimulate CTLs in a CD4-dependent manner, J Immunol, 176, 2357, 10.4049/jimmunol.176.4.2357 Gilboa, 2004, Cancer immunotherapy with mRNA-transfected dendritic cells, Immunol Rev, 199, 251, 10.1111/j.0105-2896.2004.00139.x Paczesny, 2004, Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor–derived dendritic cells, J Exp Med, 199, 1503, 10.1084/jem.20032118 Fay, 2006, Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34(+) progenitor–derived dendritic cells, Cancer Immunol Immunother, 55, 1209, 10.1007/s00262-005-0106-6 Thurner, 1999, Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma, J Exp Med, 190, 1669, 10.1084/jem.190.11.1669 Mannering, 1997, HLA-DR1-restricted bcr-abl (b3a2)-specific CD4+ T lymphocytes respond to dendritic cells pulsed with b3a2 peptide and antigen-presenting cells exposed to b3a2-containing cell lysates, Blood, 90, 290, 10.1182/blood.V90.1.290